The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Malyugin B.E.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Sidorova A.V.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Starostina A.V.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Zhuravlev A.S.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Khaletskaya A.A.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Eliseeva M.A.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Smirnova E.A.

Federal Institute of Industrial Property of the Federal Service for Intellectual Property, Patents and Trademarks

Pharmacological modulation of wound healing in glaucoma surgery

Authors:

Malyugin B.E., Sidorova A.V., Starostina A.V., Zhuravlev A.S., Khaletskaya A.A., Eliseeva M.A., Smirnova E.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2022;138(4): 136‑143

DOI: 10.17116/oftalma2022138041136

Read: 2425 times

Download PDF (RU)
Contact the author
Table of contents

PHARMACOLOGICAL MODULATION OF WOUND HEALING IN GLAUCOMA SURGERY
PHARMACOLOGICAL MODULATION OF WOUND HEALING IN GLAUCOMA SURGERY

To cite this article:

Malyugin BE, Sidorova AV, Starostina AV, Zhuravlev AS, Khaletskaya AA, Eliseeva MA, Smirnova EA. Pharmacological modulation of wound healing in glaucoma surgery. Russian Annals of Ophthalmology. 2022;138(4):136‑143. (In Russ.)
https://doi.org/10.17116/oftalma2022138041136

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Despite the well-known effectiveness of pharmacological glaucoma therapy, surgical approach remains one of the main treatment options for some forms and stages of the disease. The long-term success of glaucoma surgery depends on the intensity of local wound healing processes at the surgical site. The most common way to influence healing processes in surgical treatment of glaucoma is the use of antimetabolites. However, given the high risk of serious complications associated with their use, the search for new drugs devoid of these disadvantages continues. The aim of this review is to describe the efficacy and safety of both currently used and upcoming pharmacological ways to influence the wound healing process after glaucoma surgery in order to improve the stability of hypotensive effect.

Keywords:

glaucoma
mitomycin C
5-Fluorouracil
anti-VEGF agents
scarring

Authors:

Malyugin B.E.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Sidorova A.V.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Starostina A.V.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Zhuravlev A.S.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Khaletskaya A.A.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Eliseeva M.A.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Smirnova E.A.

Federal Institute of Industrial Property of the Federal Service for Intellectual Property, Patents and Trademarks

Received:

22.03.2021

Accepted:

16.06.2021

Close metadata

References:

  1. Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis. Ophthalmology. 2014;121(11): 2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013
  2. Bonniard AA, Yeung JY, Chan CC, Birt CM. Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opin Drug Metab Toxicol. 2016;12(11): 1279-1289. https://doi.org/10.1080/17425255.2016.1209481
  3. Mathew R, Barton K. Anti-Vascular Endothelial Growth Factor Therapy in Glaucoma Filtration Surgery. Am J Ophthalmol. 2011;152(1):10-15.e2.  https://doi.org/10.1016/j.ajo.2011.03.013
  4. Skuta GL, Parrish RK. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32(3):149-170.  https://doi.org/10.1016/0039-6257(87)90091-9
  5. Holló G. Wound Healing and Glaucoma Surgery: Modulating the Scarring Process with Conventional Antimetabolites and New Molecules. Glaucoma Surg. 2012;50:79-89.  https://doi.org/10.1159/000334790
  6. Lama PJ, Fechtner RD. Antifibrotics and Wound Healing in Glaucoma Surgery. Surv Ophthalmol. 2003;48(3):314-346.  https://doi.org/10.1016/S0039-6257(03)00038-9
  7. Fan Gaskin JC, Nguyen DQ, Soon Ang G, O’Connor J, Crowston JG. Wound Healing Modulation in Glaucoma Filtration Surgery — Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I). J Curr Glaucoma Pract. 2014;8(2):37-45.  https://doi.org/10.5005/jp-journals-10008-1159
  8. Amoozgar B, Lin SC, Han Y, Kuo J. A role for antimetabolites in glaucoma tube surgery: current evidence and future directions. Curr Opin Ophthalmol. 2016;27(2):164-169.  https://doi.org/10.1097/ICU.0000000000000244
  9. Robin AL, Ramakrishnan R, Krishnadas R, Smith SD, Katz JD, Selvaraj S, Skuta GL, Bhatnagar R. A Long-term Dose-Response Study of Mitomycin in Glaucoma Filtration Surgery. Arch Ophthalmol. 1997;115(8):969-974.  https://doi.org/10.1001/archopht.1997.01100160139001
  10. Kim YY, Sexton RM, Shin DH, Kim C, Ginde SA, Ren J, Lee D, Kupin TH. Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. Am J Ophthalmol. 1998; 126(6):755-762.  https://doi.org/10.1016/S0002-9394(98)00279-7
  11. Wilkins MR, Indar A, Wormald RP. Intra-operative Mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2001;(1):CD002897. https://doi.org/10.1002/14651858.CD002897
  12. Beckers HJM, Kinders KC, Webers CAB. Five-year results of trabeculectomy with mitomycin C. Graefe’s Arch Clin Exp Ophthalmol. 2003;241(2):106-110.  https://doi.org/10.1007/s00417-002-0621-5
  13. Palanca-Capistrano AM, Hall J, Cantor LB, Morgan L, Hoop J, WuDunn D. Long-term Outcomes of Intraoperative 5-Fluorouracil versus Intraoperative Mitomycin C in Primary Trabeculectomy Surgery. Ophthalmology. 2009; 116(2):185-190.  https://doi.org/10.1016/j.ophtha.2008.08.009
  14. Cheng J-W, Cai J-P, Li Y, Wei R-L. Intraoperative Mitomycin C for Nonpenetrating Glaucoma Surgery: A Systematic Review and Meta-analysis. J Glaucoma. 2011;20(5):322-326.  https://doi.org/10.1097/IJG.0b013e3181e3d2f7
  15. Mahdy RAR. Adjunctive Use of Bevacizumab Versus Mitomycin C With Ahmed Valve Implantation in Treatment of Pediatric Glaucoma. J Glaucoma. 2011;20(7):458-463.  https://doi.org/10.1097/IJG.0b013e3181efbea5
  16. Alvarado JA, Hollander DA, Juster RP, Lee LC. Ahmed Valve Implantation with Adjunctive Mitomycin C and 5-Fluorouracil: Long-term Outcomes. Am J Ophthalmol. 2008;146(2):276-284.e2.  https://doi.org/10.1016/j.ajo.2008.04.008
  17. Al-Mobarak F, Khan AO. Two-Year Survival of Ahmed Valve Implantation in the First 2 Years of Life with and without Intraoperative Mitomycin-C. Ophthalmology. 2009;116(10):1862-1865. https://doi.org/10.1016/j.ophtha.2009.03.030
  18. Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: A prospective randomized clinical trial. Ophthalmology. 2004; 111(6):1071-1076. https://doi.org/10.1016/j.ophtha.2003.09.037
  19. Abraham LM, Selva D, Casson R, Leibovitch I. The Clinical Applications of Fluorouracil in Ophthalmic Practice. Drugs. 2007;67(2):237-255.  https://doi.org/10.2165/00003495-200767020-00005
  20. Group TFFSS. Five-year Follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1996;121(4):349-366.  https://doi.org/10.1016/S0002-9394(14)70431-3
  21. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with Mitomycin: A Comparative Study with Fluorouracil. Arch Ophthalmol. 1991; 109(12):1693-1698. https://doi.org/10.1001/archopht.1991.01080120077030
  22. Skuta GL, Beeson CC, Higginbotham EJ, Lichter PR, Musch DC, Bergstrom TJ, Klein TB, Falck FY. Intraoperative Mitomycin versus Postoperative 5-Fluorouracil in High-risk Glaucoma Filtering Surgery. Ophthalmology. 1992;99(3):438-444.  https://doi.org/10.1016/S0161-6420(92)31951-7
  23. Cabourne E, Clarke JC, Schlottmann PG, Evans JR. Mitomycin C versus 5‐Fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev. 2015;2015(11):CD006259. https://doi.org/10.1002/14651858.CD006259.pub2
  24. DeBry PW. Incidence of Late-Onset Bleb-Related Complications Following Trabeculectomy With Mitomycin. Arch Ophthalmol. 2002;120(3):297.  https://doi.org/10.1001/archopht.120.3.297
  25. Storr-Paulsen T, Norregaard JC, Ahmed S, Storr-Paulsen A. Corneal Endothelial Cell Loss After Mitomycin C-augmented Trabeculectomy. J Glaucoma. 2008;17(8):654-657.  https://doi.org/10.1097/IJG.0b013e3181659e56
  26. Wong J, Wang N, Miller JW, Schuman JS. Modulation of Human Fibroblast Activity by Selected Angiogenesis Inhibitors. Exp Eye Res. 1994;58(4):439-451.  https://doi.org/10.1006/exer.1994.1037
  27. Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, DiPietro LA. Regulation of scar formation by vascular endothelial growth factor. Lab Invest. 2008;88(6):579-590.  https://doi.org/10.1038/labinvest.2008.36
  28. Nomoto H, Shiraga F, Kuno N, Kimura E, Fujii S, Shinomiya K, Nugent AK, Hirooka K, Baba T. Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits. Invest Ophthalmol Vis Sci. 2009;50(10):4807-4813. https://doi.org/10.1167/iovs.08-3148
  29. SooHoo JR, Seibold LK, Pantcheva MB, Kahook MY. Aflibercept for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2015;43(9):803-807.  https://doi.org/10.1111/ceo.12559
  30. Waisbourd M, Shemesh G, Kurtz S, Rachmiel R, Moisseiev E, Zayit-Soudri S, Loewenstein A, Barequet I. Topical Bevacizumab for Neovascular Glaucoma: A Pilot Study. Pharmacology. 2014;93(3-4):108-112.  https://doi.org/10.1159/000358600
  31. Jonas JB, Golubkina L, Libondi T, Rensch F. Intravitreal bevacizumab for neovascular glaucoma. Acta Ophthalmologica. 2010;88(2):e22-e23.  https://doi.org/10.1111/j.1755-3768.2008.01453.x
  32. Mamikonyan VR, Petrov SYu, Mazurova YuV, Safonova DM, Sorokin AS. Postoperative adjuvant subconjunctival ranibizumab in enhancing trabeculectomy efficacy. National Journal Glaucoma. 2016;15(2):61-73. (In Russ.).
  33. Chen C-H, Lai I-C, Wu P-C, Chen Y-J, Chen Y-H, Lee J-J, Liu Y-C, Kuo H-K. Adjunctive Intravitreal Bevacizumab-Combined Trabeculectomy Versus Trabeculectomy Alone in the Treatment of Neovascular Glaucoma. J Ocul Pharm Ther. 2010;26(1):111-118.  https://doi.org/10.1089/jop.2009.0055
  34. Hwang HB, Han JW, Yim HB, Lee NY. Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma: systematic literature review. J Ocul Pharmacol Ther. 2015;31(4):198-203.  https://doi.org/10.1089/jop.2014.0108
  35. Vahedian Z, Mafi M, Fakhraie G, Zarei R, Eslami Y, Ghadimi H, et al. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial. J Glaucoma. 2017;26(9):829-834.  https://doi.org/10.1097/IJG.0000000000000741
  36. Slabaugh M, Salim S. Use of Anti-VEGF Agents in Glaucoma Surgery. J Ophthalmol. 2017;2017:1645269. https://doi.org/10.1155/2017/1645269
  37. Sengupta S, Venkatesh R, Ravindran RD. Safety and Efficacy of Using Off-label Bevacizumab Versus Mitomycin C to Prevent Bleb Failure in a Single-site Phacotrabeculectomy by a Randomized Controlled Clinical Trial. J Glaucoma. 2012;21(7):450-459.  https://doi.org/10.1097/IJG.0b013e31821826b2
  38. Miraftabi A, Nilforushan N. Wound Dehiscence and Device Migration after Subconjunctival Bevacizumab Injection with Ahmed Glaucoma Valve Implantation. J Ophthalmic Vis Res. 2016;11(1):112-115.  https://doi.org/10.4103/2008-322X.180703
  39. Germanova VN, Volzhanin AV, Zolotarev AV, Karlova EV, Petrov SYu. Cyclosporine A in glaucoma surgery: perspectives and opportunities. National Journal Glaucoma. 2017;16(2):92-100. (In Russ.).
  40. Lattanzio FAJ, Crouch ERJ, Mitrev PV, Williams PB, Allen RC. Cyclosporin as an Adjunct to Glaucoma Filtration Surgery. J Glaucoma. 2005;14(6): 441-447.  https://doi.org/10.1097/01.ijg.0000185432.63408.1e
  41. Turaçli E, Gündüz K, Aktan G, Tamer C. A Comparative Clinical Trial of Mitomycin C and Cyclosporin a in Trabeculectomy. Eur J Ophthalmol. 1996; 6(4):398-401.  https://doi.org/10.1177/112067219600600410
  42. Lankaranian D, Patel R, Moster MR, Wizov S, Alvim HS, Lopes JF, Tong M, Spaeth GL. A Randomized Prospective Clinical Trial of the Efficacy of Cyclosporine Ophthalmic Emulsion 0.05% Following Trabeculectomy With Antimetabolite. Invest Ophthalmol Vis Sci. 2006;47(13):5486-5486.
  43. Arslan S, Aydemir O, Güler M, Dağlı AF. Modulation of Postoperative Scarring with Tacrolimus and Octreotide in Experimental Glaucoma Filtration Surgery. Curr Eye Res. 2012;37(3):228-233.  https://doi.org/10.3109/02713683.2011.635404
  44. Wang X-C, Wang T, Zhang Y, Wang L-L, Zhao R-Y, Tan W. Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery. Eur Rev Med Pharmacol Sci. 2018;22(10): 2934-2940. https://doi.org/10.26355/eurrev_201805_15047
  45. Masoumpour MB, Nowroozzadeh MH, Razeghinejad MR. Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries. Open Ophthalmol J. 2016;10(1):68-85.  https://doi.org/10.2174/1874364101610010068
  46. Cordeiro MF. Role of transforming growth factor beta in conjunctival scarring. Clin Sci (Lond). 2003;104(2):181-187.  https://doi.org/10.1042/CS20020150
  47. Mietz H, Krieglstein GK. Suramin to enhance glaucoma filtering procedures: A clinical comparison with mitomycin. Ophthalm Surg Lasers. 2001; 32(5):358-369. 
  48. Chihara E, Dong J, Ochiai H, Hamada S. Effects of Tranilast on Filtering Blebs: A Pilot Study. J Glaucoma. 2002;11(2):127-133.  https://doi.org/10.1097/00061198-200204000-00008
  49. Li DQ, Lee SB, Gunja-Smith Z, Liu Y, Solomon A, Meller D, Tseng SC. Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol. 2001;119(1):71-80. 
  50. Daniels JT, Cambrey AD, Occleston NL, Garrett Q, Tarnuzzer RW, Schultz GS, Khaw PT. Matrix Metalloproteinase Inhibition Modulates Fibroblast-Mediated Matrix Contraction and Collagen Production In Vitro. Invest Ophthalmol Vis Sci. 2003;44(3):1104-1110. https://doi.org/10.1167/iovs.02-0412
  51. Wong TTL, Mead AL, Khaw PT. Prolonged Antiscarring Effects of Ilomastat and MMC after Experimental Glaucoma Filtration Surgery. Invest Ophthalmol Vis Sci. 2005;46(6):2018-2022. https://doi.org/10.1167/iovs.04-0820
  52. Margaritopoulos GA, Vasarmidi E, Antoniou KM. Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy. Core Evid. 2016;11:11-22.  https://doi.org/10.2147/CE.S76549
  53. Lin X, Yu M, Wu K, Yuan H, Zhong H. Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon’s Fibroblasts In Vitro. Invest Ophthalmol Vis Sci. 2009;50(8):3763-3770. https://doi.org/10.1167/iovs.08-2815
  54. Zhong H, Sun G, Lin X, Wu K, Yu M. Evaluation of Pirfenidone as a New Postoperative Antiscarring Agent in Experimental Glaucoma Surgery. Invest Ophthalmol Vis Sci. 2011;52(6):3136-3142. https://doi.org/10.1167/iovs.10-6240
  55. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart J-M, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert J-M, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001; 7(5):575-583.  https://doi.org/10.1038/87904
  56. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert J-M, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8(8):831-840.  https://doi.org/10.1038/nm731
  57. Van Bergen T, Van de Veire S, Vandewalle E, Moons L, Stalmans I. Role of placental growth factor (PLGF) in wound healing after glaucoma filtration surgery. Bull Soc Belge Ophtalmol. 2011;(317):65-66. 
  58. Bergen TV, Jonckx B, Hollanders K, Sijnave D, Velde SV de, Vandewalle E, Moons L, Stassen J-M, Stalmans I. Inhibition of placental growth factor improves surgical outcome of glaucoma surgery. J Cell Mol Med. 2013;17(12): 1632-1643. https://doi.org/10.1111/jcmm.12151
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.